Literature DB >> 8393070

Characterization of the trypsin-like enzymes of Porphyromonas gingivalis W83 using a radiolabelled active-site-directed inhibitor.

M A Curtis1, M Ramakrishnan, J M Slaney.   

Abstract

The trypsin-like enzyme activity of Porphyromonas gingivalis is an important virulence determinant of this organism in destructive periodontitis. An active-site-directed inhibitor, tyrosyl-alanyl-lysyl-arginine chloromethyl ketone (YAKR-CK) was radio-iodinated and used with SDS-PAGE and autoradiography to determine the number and molecular masses of enzymes with trypsin-like specificity produced by P. gingivalis W83. Two forms (I + II) were detected in both crude culture supernatant and whole cell sonicates. Protease I was a sharp band (47 kDa) on reducing SDS-PAGE; Protease II electrophoresed as a diffuse band in the range 70-90 kDa. The specificity with which the inhibitor bound to Protease I was established in competition experiments using other active-site-directed agents. YAKR-CK inhibited P. gingivalis whole cell haemagglutination, supporting the possible role of trypsin-like proteases of this organism in adhesion mechanisms.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8393070     DOI: 10.1099/00221287-139-5-949

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  14 in total

1.  Characterization of an adherence and antigenic determinant of the ArgI protease of Porphyromonas gingivalis which is present on multiple gene products.

Authors:  M A Curtis; J Aduse-Opoku; J M Slaney; M Rangarajan; V Booth; J Cridland; P Shepherd
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Porphyrin-mediated cell surface heme capture from hemoglobin by Porphyromonas gingivalis.

Authors:  Mayuri Paramaesvaran; Ky-Anh Nguyen; Elizabeth Caldon; James A McDonald; Sherean Najdi; Graciel Gonzaga; David B Langley; Arthur DeCarlo; Maxwell J Crossley; Neil Hunter; Charles A Collyer
Journal:  J Bacteriol       Date:  2003-04       Impact factor: 3.490

3.  Targeted disruption of fibronectin-integrin interactions in human gingival fibroblasts by the RI protease of Porphyromonas gingivalis W50.

Authors:  M A Scragg; S J Cannon; M Rangarajan; D M Williams; M A Curtis
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

4.  Biochemical characterization of the arginine-specific proteases of Porphyromonas gingivalis W50 suggests a common precursor.

Authors:  M Rangarajan; S J Smith; S U; M A Curtis
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

5.  Characterization of Porphyromonas gingivalis-induced degradation of epithelial cell junctional complexes.

Authors:  J Katz; V Sambandam; J H Wu; S M Michalek; D F Balkovetz
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

6.  Mechanisms of resistance of Porphyromonas gingivalis to killing by serum complement.

Authors:  Jennifer M Slaney; Alexandra Gallagher; Joseph Aduse-Opoku; Keith Pell; Michael A Curtis
Journal:  Infect Immun       Date:  2006-09       Impact factor: 3.441

7.  Expression of the peptide antibiotic human beta-defensin 1 in cultured gingival epithelial cells and gingival tissue.

Authors:  S Krisanaprakornkit; A Weinberg; C N Perez; B A Dale
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

8.  Characterization, genetic analysis, and expression of a protease antigen (PrpRI) of Porphyromonas gingivalis W50.

Authors:  J Aduse-Opoku; J Muir; J M Slaney; M Rangarajan; M A Curtis
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

9.  Nuclear targeting of Porphyromonas gingivalis W50 protease in epithelial cells.

Authors:  Margaret A Scragg; Asil Alsam; Minnie Rangarajan; Jennifer M Slaney; Philip Shepherd; David M Williams; Michael A Curtis
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

10.  The multiple forms of trypsin-like activity present in various strains of Porphyromonas gingivalis are due to the presence of either Arg-gingipain or Lys-gingipain.

Authors:  J Potempa; R Pike; J Travis
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.